{"id":"https://openalex.org/W7015876239","doi":null,"title":"Upfront FOLFOXIRI plus bevacizumab with or without atezolizumab in the treatment of patients with metastatic colorectal cancer (ATEZOTRIBE): a multicentre, open-label, phase 2, randomised controlled trial","display_name":"Upfront FOLFOXIRI plus bevacizumab with or without atezolizumab in the treatment of patients with metastatic colorectal cancer (ATEZOTRIBE): a multicentre, open-label, phase 2, randomised controlled trial","alternate_titles":[],"publication_year":2022,"publication_date":"2022-06-30","ids":{"openalex":"https://openalex.org/W7015876239"},"language":"en","primary_location":{"id":"pmh:oai:etd.adm.unipi.it:etd-05202022-104316","doi":null,"is_oa":false,"landing_page_url":"https://etd.adm.unipi.it/theses/available/etd-05202022-104316/","pdf_url":null,"source":{"id":"https://openalex.org/S4306401800","display_name":"Electronic Theses and Dissertations Repository (University of Pisa)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I108290504","host_organization_name":"University of Pisa","host_organization_lineage":["https://openalex.org/I108290504"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"https://etd.adm.unipi.it/theses/available/etd-05202022-104316/","raw_type":"text"},"parent_works":[],"lineage":["https://openalex.org/W7015876239"],"child_works_count":0,"type":"dissertation","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103808013","display_name":"Gemma Zucchelli","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"ZUCCHELLI, GEMMA","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5103808013"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":true,"primary_topic":{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.9848999977111816,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.9848999977111816,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.014000000432133675,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10335","display_name":"Colorectal Cancer Surgical Treatments","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/metastatic-colorectal-cancer","display_name":"metastatic colorectal cancer","score":1.0},{"id":"https://openalex.org/keywords/folfoxiri","display_name":"FOLFOXIRI","score":0.9779999852180481},{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":0.9750000238418579},{"id":"https://openalex.org/keywords/atezolizumab","display_name":"atezolizumab","score":0.9990000128746033},{"id":"https://openalex.org/keywords/pd-l1-blockade","display_name":"PD-L1 blockade","score":0.7839999794960022},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.8999999761581421},{"id":"https://openalex.org/keywords/first-line-treatment","display_name":"first-line therapy","score":0.7300000190734863},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.7039999961853027},{"id":"https://openalex.org/keywords/proficient-mismatch-repair","display_name":"proficient mismatch repair","score":0.8349999785423279},{"id":"https://openalex.org/keywords/immunogenicity","display_name":"immunogenicity","score":0.6370000243186951},{"id":"https://openalex.org/keywords/maintenance-therapy","display_name":"maintenance therapy","score":0.5580000281333923},{"id":"https://openalex.org/keywords/irinotecan","display_name":"irinotecan","score":0.6240000128746033},{"id":"https://openalex.org/keywords/oxaliplatin","display_name":"oxaliplatin","score":0.9950000047683716}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9381999969482422},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.8889999985694885},{"id":"https://openalex.org/C2775949291","wikidata":"https://www.wikidata.org/wiki/Q20707748","display_name":"Atezolizumab","level":5,"score":0.7324000000953674},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7160999774932861},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.671999990940094},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6072999835014343},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.5450000166893005},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.5364000201225281},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4406000077724457},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.41679999232292175},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.413100004196167},{"id":"https://openalex.org/C2777863537","wikidata":"https://www.wikidata.org/wiki/Q357896","display_name":"Adjuvant","level":2,"score":0.35589998960494995},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3515999913215637},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.3391999900341034},{"id":"https://openalex.org/C2776907518","wikidata":"https://www.wikidata.org/wiki/Q1734165","display_name":"Performance status","level":3,"score":0.3328000009059906},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.3091000020503998},{"id":"https://openalex.org/C2778336483","wikidata":"https://www.wikidata.org/wiki/Q5090632","display_name":"Chemotherapy regimen","level":3,"score":0.30250000953674316},{"id":"https://openalex.org/C2779013556","wikidata":"https://www.wikidata.org/wiki/Q181876","display_name":"Metastasis","level":3,"score":0.2939000129699707},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.2867000102996826},{"id":"https://openalex.org/C2780456651","wikidata":"https://www.wikidata.org/wiki/Q238512","display_name":"Fluorouracil","level":3,"score":0.2858000099658966},{"id":"https://openalex.org/C204243189","wikidata":"https://www.wikidata.org/wiki/Q1363085","display_name":"Randomization","level":3,"score":0.2671000063419342},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.2651999890804291},{"id":"https://openalex.org/C2778850193","wikidata":"https://www.wikidata.org/wiki/Q3775974","display_name":"Febrile neutropenia","level":4,"score":0.26409998536109924},{"id":"https://openalex.org/C2776999253","wikidata":"https://www.wikidata.org/wiki/Q1304270","display_name":"Combination therapy","level":2,"score":0.2628999948501587},{"id":"https://openalex.org/C2777982462","wikidata":"https://www.wikidata.org/wiki/Q2481887","display_name":"Adjuvant therapy","level":3,"score":0.26249998807907104},{"id":"https://openalex.org/C2778283404","wikidata":"https://www.wikidata.org/wiki/Q6736822","display_name":"Maintenance therapy","level":3,"score":0.25290000438690186},{"id":"https://openalex.org/C202953159","wikidata":"https://www.wikidata.org/wiki/Q382695","display_name":"Intention-to-treat analysis","level":3,"score":0.24690000712871552},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.23819999396800995},{"id":"https://openalex.org/C2780739268","wikidata":"https://www.wikidata.org/wiki/Q2112244","display_name":"Progression-free survival","level":3,"score":0.23739999532699585},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.2363000065088272},{"id":"https://openalex.org/C2780283643","wikidata":"https://www.wikidata.org/wiki/Q2110267","display_name":"Primary tumor","level":4,"score":0.23479999601840973},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.22609999775886536},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.2206999957561493},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.20630000531673431},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.19220000505447388},{"id":"https://openalex.org/C2778822529","wikidata":"https://www.wikidata.org/wiki/Q1951525","display_name":"Progressive disease","level":3,"score":0.188400000333786},{"id":"https://openalex.org/C2780873365","wikidata":"https://www.wikidata.org/wiki/Q496812","display_name":"Leukopenia","level":3,"score":0.1785999983549118},{"id":"https://openalex.org/C2778164965","wikidata":"https://www.wikidata.org/wiki/Q1620196","display_name":"Brain metastasis","level":4,"score":0.1784999966621399},{"id":"https://openalex.org/C2778435480","wikidata":"https://www.wikidata.org/wiki/Q840387","display_name":"Colonoscopy","level":4,"score":0.17589999735355377},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.17569999396800995}],"mesh":[],"locations_count":1,"locations":[{"id":"pmh:oai:etd.adm.unipi.it:etd-05202022-104316","doi":null,"is_oa":false,"landing_page_url":"https://etd.adm.unipi.it/theses/available/etd-05202022-104316/","pdf_url":null,"source":{"id":"https://openalex.org/S4306401800","display_name":"Electronic Theses and Dissertations Repository (University of Pisa)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I108290504","host_organization_name":"University of Pisa","host_organization_lineage":["https://openalex.org/I108290504"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"https://etd.adm.unipi.it/theses/available/etd-05202022-104316/","raw_type":"text"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4281627748","https://openalex.org/W3044484797","https://openalex.org/W7056479891","https://openalex.org/W4399559384","https://openalex.org/W4379283278","https://openalex.org/W4406869624","https://openalex.org/W3204285816","https://openalex.org/W4281990460","https://openalex.org/W7000534663","https://openalex.org/W4391090869"],"abstract_inverted_index":{"Background":[0],"Immune":[1],"checkpoint":[2],"inhibitors":[3],"have":[4],"not":[5],"shown":[6],"clinical":[7],"benefit":[8,58],"to":[9,42,53,67,142,171,220,238,433,458],"metastatic":[10,75,122,474],"colorectal":[11,76,123,475],"patients":[12,73,90,164,264,290,377,387,414,423,470],"who":[13,129,265],"had":[14],"proficient":[15],"mismatch":[16],"repair":[17],"(pMMR)":[18],"or":[19,48,234,247],"microsatellite":[20],"stable":[21],"(MSS)":[22],"tumours":[23],"in":[24,72,136,263,298,304,332,342,378,388,411,415,420,424,442,449,469],"previous":[25,151],"studies.":[26],"Both":[27],"an":[28,95,110],"active":[29],"combination":[30],"chemotherapy":[31],"(FOLFOXIRI;":[32],"fluorouracil,":[33],"leucovorin,":[34,189],"oxaliplatin,":[35,186],"and":[36,38,105,125,150,190,202,229,285,294,302,336,398,419,437,465],"irinotecan)":[37],"bevacizumab":[39,71,198,232,462],"seem":[40],"able":[41],"increase":[43],"the":[44,60,63,174,203,207,272,299,305,333,343,379,389,416,425,443,450],"immunogenicity":[45],"of":[46,57,62,89,103,114,271,375,385,456],"pMMR":[47],"MSS":[49],"tumours.":[50],"We":[51],"aimed":[52],"provide":[54],"preliminary":[55],"evidence":[56],"from":[59,132],"addition":[61,455],"anti-PD-L1":[64],"agent":[65],"atezolizumab":[66,211,457],"first-line":[68,178,459],"FOLFOXIRI":[69,179,460],"plus":[70,197,210,231,461],"with":[74,94,109,116,227,233,471],"cancer.":[77,476],"Methods":[78],"AtezoTRIBE":[79],"was":[80,253,261,316,326],"a":[81,158,166],"multicentre,":[82],"open-label,":[83],"randomised,":[84],"controlled,":[85],"phase":[86],"2":[87],"study":[88,273,276],"(aged":[91],"18\u201370":[92],"years":[93,108],"Eastern":[96],"Cooperative":[97],"Oncology":[98],"Group":[99],"[ECOG]":[100],"performance":[101,112,145],"status":[102,113],"0-2":[104],"aged":[106],"71\u201375":[107],"ECOG":[111,144],"0),":[115],"histologically":[117],"confirmed,":[118],"unresectable,":[119],"previously":[120,472],"untreated":[121,473],"cancer":[124],"adequate":[126],"organ":[127],"function,":[128],"were":[130,139,217,291,371,409,440,447],"recruited":[131],"22":[133],"oncology":[134],"centres":[135],"Italy.":[137],"Patients":[138],"stratified":[140],"according":[141,237],"centre,":[143],"status,":[146],"primary":[147,251],"tumour":[148],"site,":[149],"adjuvant":[152],"therapy.":[153],"A":[154],"randomisation":[155,239],"system":[156],"incorporating":[157],"minimisation":[159],"algorithm":[160],"randomly":[161,292],"assigned":[162,293],"(1:2)":[163],"via":[165],"masked":[167],"web-based":[168],"allocation":[169],"procedure":[170],"two":[172],"groups:":[173],"control":[175,300,344,390,426,451],"group":[176,205,301,335,345,381,418],"received":[177,206,266,295],"(intravenous":[180],"165":[181],"mg/m\u00b2":[182,185,188,192],"irinotecan,":[183],"85":[184],"200":[187],"3200":[191],"\ufb02uorouracil":[193],"as":[194],"48-h":[195],"infusion)":[196],"(5":[199],"mg/kg":[200],"intravenously),":[201],"experimental":[204,306,334,380,417,444],"same":[208],"regimen":[209],"(840":[212],"mg":[213],"intravenously).":[214],"Combination":[215],"treatments":[216],"administered":[218],"up":[219],"eight":[221],"14-day":[222],"cycles":[223],"followed":[224],"by":[225,257],"maintenance":[226],"fluorouracil":[228],"leucovorin":[230],"without":[235],"atezolizumab,":[236],"group,":[240],"until":[241],"disease":[242],"progression,":[243],"unacceptable":[244],"adverse":[245,369,407],"events,":[246],"consent":[248],"withdrawal.":[249],"The":[250,275,363,454],"endpoint":[252],"progression-free":[254,324,467],"survival,":[255],"analysed":[256],"intention-to-treat":[258],"principle.":[259],"Safety":[260],"assessed":[262],"at":[267],"least":[268],"one":[269],"dose":[270],"treatment.":[274],"recruitment":[277],"is":[278,463],"completed.":[279],"Findings":[280],"Between":[281],"Nov":[282],"30,":[283],"2018,":[284],"Feb":[286],"26,":[287],"2020,":[288],"218":[289],"treatment":[296],"(73":[297],"145":[303],"group).":[307],"At":[308],"data":[309],"cut-off":[310],"(Aug":[311],"1,":[312],"2021)":[313],"median":[314],"follow-up":[315],"19.9":[317],"months":[318,328,338],"(interquartile":[319],"range":[320],"[IQR]":[321],"17.3\u201323.9).":[322],"Median":[323],"survival":[325,468],"13.1":[327],"(80%":[329,339],"CI":[330,340,351,358],"12.5\u201313.8)":[331],"11.5":[337],"10.0\u201312.6)":[341],"(hazard":[346],"ratio":[347],"[HR]":[348],"0.69,":[349],"80%":[350,357],"0.56\u20130.85;":[352],"p=0.012;":[353],"adjusted":[354],"HR":[355],"0.70,":[356],"0.57-0.87;":[359],"log-rank":[360],"test":[361],"p=0.018).":[362],"most":[364],"frequent":[365],"all-cause":[366],"grade":[367],"3\u20134":[368],"events":[370,408],"neutropenia":[372,400],"(59":[373],"[42%]":[374],"142":[376],"versus":[382,395,403],"26":[383],"[36%]":[384],"72":[386],"group),":[391],"diarrhoea":[392],"(21":[393],"[15%]":[394],"9":[396],"[13%]),":[397],"febrile":[399],"(14":[401],"[10%]":[402],"7":[404],"[10%]).":[405],"Serious":[406],"reported":[410,441,448],"39":[412],"(27%)":[413],"19":[421],"(26%)":[422],"group.":[427,452],"Two":[428],"(1%)":[429],"treatment-related":[430],"deaths":[431],"(due":[432],"acute":[434],"myocardial":[435],"infarction":[436],"bronchopulmonary":[438],"haemorrhage)":[439],"group;":[445],"none":[446],"Interpretation":[453],"safe":[464],"improved":[466],"Trial":[477],"registration:":[478],"Clinicaltrials.gov":[479],"Identifier:":[480],"NCT03721653.":[481]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W7015876239","counts_by_year":[],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2025-10-10T00:00:00"}
